DUBLIN, Ohio & TEL AVIV, Israel--(BUSINESS WIRE)--Navidea Biopharmaceuticals Inc., (NYSE MKT: NAVB), a biopharmaceutical company focused on the development and commercialization of precision diagnostics, therapeutics and radiopharmaceutical agents, today announced that the Tel Aviv Stock Exchange (TASE) has approved the new listing of Navidea's common stock on the TASE beginning on Tuesday, September 8, 2015 under the ticker symbol NAVB. The Company's common stock will be listed on both the NYSE MKT in the United States and the TASE in Israel. The Company also announced today that, based upon NavidHelp employers find you! Check out all the jobs and post your resume.
